Johnson & Johnson Lawsuits Over Talcum Powder, Opioids and Other Products May Cost Over $20B to Settle: Report: WSJ
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.…
«
»
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.…
A Philadelphia jury has ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who developed breasts as a child due to the side effects of Risperdal.…
A new study warns that giving dementia patients trazodone could be as risky as giving them atypical antipsychotics.…
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.…
A federal judge cleared the way for a class action lawsuit against Missouri officials, who plaintiffs say allowed unmonitored and uncontrolled prescribing of psychotropic drugs to foster children.…
The Pennsylvania Supreme Court will hear an appeal that could determine when the statute of limitations for thousands of Risperdal breast growth lawsuits.…
A new report by Human Rights Watch details rampant overuse of antipsychotics in U.S. nursing homes, which are used as a form of chemical restraint on patients with dementia.…
A ruling by a panel of Pennsylvania judges opens the way for about 6,000 plaintiffs with Risperdal lawsuits filed in that state to seek punitive damages from Johnson & Johnson over claims that the drug causes breast growth in boys.…
The Pennsylvania Superior Court has overturned Johnson & Johnson’s only win before a jury in Risperdal litigation in that state, ordering a new trial.…
A Risperdal lawsuit has resulted in a $1 million verdict for a 24-year-old man who began growing breasts after he started taking the drug when he was 9-years-old.…